Showing results (1271-1280 of 1,400) with videos related to

Sort By:
Pageof 140
Theranostics|August 1, 2022
Transient upregulation of EGR1 signaling enhances kidney repair by activating SOX9<sup>+</sup> renal tubular cellsJian-Wen Chen, Meng-Jie Huang, Xiao-Niao Chen, et al.
Drug Design, Development and Therapy|October 8, 2015
Chamaejasmin B exerts anti-MDR effect in vitro and in vivo via initiating mitochondria-dependant intrinsic apoptosis pathwayYa Jie Wang, Qi Li, Hong Bin Xiao, et al.
Journal of Diabetes|March 21, 2014
Validation of a differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases and the establishment of a new diagnostic modelMo-yan Liu, Xiang-mei Chen, Xue-feng Sun, et al.
European Journal of Medicinal Chemistry|May 19, 2018
From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4Ding-Ding Gao, Hui-Xia Dou, Hai-Xia Su, et al.
BMC Medicine|July 7, 2024
Mining the interpretable prognostic features from pathological image of intrahepatic cholangiocarcinoma using multi-modal deep learningGuang-Yu Ding, Wei-Min Tan, You-Pei Lin, et al.
BMC Cancer|October 9, 2010
Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancerDa-zhi Xu, Qi-rong Geng, Ying Tian, et al.
ACS Chemical Biology|May 18, 2022
Inhibiting C-4 Methyl Sterol Oxidase with Novel Diazaborines to Target Fungal Plant PathogensSang Hu Kim, Luke Steere, Yong-Kang Zhang, et al.
Neural Regeneration Research|February 10, 2022
(D-Ser2) oxyntomodulin recovers hippocampal synaptic structure and theta rhythm in Alzheimer's disease transgenic miceGuang-Zhao Yang, Qi-Chao Gao, Wei-Ran Li, et al.
Frontiers in Oncology|October 21, 2021
Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian CancerJiayu Chen, Ying Jin, Siyi Li, et al.
Cancer Management and Research|October 24, 2018
The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trialYong-Hong Hu, Jia-Wang Wei, Hui Chang, et al.
Pageof 140